Rohit Talwani

InstitutionMerck & Co.
AddressKenilworth
New Jersey
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in October 2020
    All Publications
    Bar chart showing 28 publications over 16 distinct years, with a maximum of 5 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 28; 21(1):897. PMID: 33115543.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    2. Wei L, Jia JD, Wang FS, Niu JQ, Zhao XM, Mu S, Liang LW, Wang Z, Hwang P, Robertson MN, Ingravallo P, Asante-Appiah E, Wei B, Evans B, Hanna GJ, Talwani R, Duan ZP, Zhdanov K, Cheng PN, Tanwandee T, Nguyen VK, Heo J, Isakov V, George J. Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study. J Gastroenterol Hepatol. 2019 Jan; 34(1):12-21. PMID: 30311701.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    3. Zamor PJ, Vierling J, Ghalib R, Luketic V, Ravendhran N, Balart L, Robertson M, Hwang P, Hanna GJ, Nguyen BY, Barr E, Talwani R, Pearlman B. Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials. Am J Gastroenterol. 2018 06; 113(6):863-871. PMID: 29695828.
      Citations: 1     Fields:    Translation:HumansCells
    4. George J, Burnevich E, Sheen IS, Heo J, Kinh NV, Tanwandee T, Cheng PN, Kim DY, Tak WY, Kizhlo S, Zhdanov K, Isakov V, Liang L, Lindore P, Ginanni J, Nguyen BY, Wahl J, Barr E, Robertson M, Ingravallo P, Talwani R. Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection. Hepatol Commun. 2018 May; 2(5):595-606. PMID: 29761174.
      Citations: 6     
    5. Asselah T, Reesink H, Gerstoft J, de Ledinghen V, Pockros PJ, Robertson M, Hwang P, Asante-Appiah E, Wahl J, Nguyen BY, Barr E, Talwani R, Serfaty L. Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis. Liver Int. 2018 09; 38(9):1583-1591. PMID: 29461687.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    6. Zeuzem S, Serfaty L, Vierling J, Cheng W, George J, Sperl J, Strasser S, Kumada H, Hwang P, Robertson M, Wahl J, Barr E, Talwani R, Platt H. The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection. J Gastroenterol. 2018 May; 53(5):679-688. PMID: 29344726.
      Citations: 8     Fields:    Translation:HumansCells
    7. Hézode C, Colombo M, Bourlière M, Spengler U, Ben-Ari Z, Strasser SI, Lee WM, Morgan L, Qiu J, Hwang P, Robertson M, Nguyen BY, Barr E, Wahl J, Haber B, Chase R, Talwani R, Marco VD. Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study. Hepatology. 2017 09; 66(3):736-745. PMID: 28256747.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    8. Osinusi A, Townsend K, Kohli A, Nelson A, Seamon C, Meissner EG, Bon D, Silk R, Gross C, Price A, Sajadi M, Sidharthan S, Sims Z, Herrmann E, Hogan J, Teferi G, Talwani R, Proschan M, Jenkins V, Kleiner DE, Wood BJ, Subramanian GM, Pang PS, McHutchison JG, Polis MA, Fauci AS, Masur H, Kottilil S. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA. 2015 Mar 24-31; 313(12):1232-9. PMID: 25706232.
      Citations: 82     Fields:    Translation:HumansCellsCTClinical Trials
    9. Kohli A, Osinusi A, Sims Z, Nelson A, Meissner EG, Barrett LL, Bon D, Marti MM, Silk R, Kotb C, Gross C, Jolley TA, Sidharthan S, Petersen T, Townsend K, Egerson D, Kapoor R, Spurlin E, Sneller M, Proschan M, Herrmann E, Kwan R, Teferi G, Talwani R, Diaz G, Kleiner DE, Wood BJ, Chavez J, Abbott S, Symonds WT, Subramanian GM, Pang PS, McHutchison J, Polis MA, Fauci AS, Masur H, Kottilil S. Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Lancet. 2015 Mar 21; 385(9973):1107-13. PMID: 25591505.
      Citations: 67     Fields:    Translation:HumansCellsCTClinical Trials
    10. Narayanan S, Townsend K, Macharia T, Majid A, Nelson A, Redfield RR, Kottilil S, Talwani R, Osinusi A. Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C. Hepatol Int. 2014 Oct; 8(4):560-6. PMID: 26202761.
      Citations: 1     Fields:    
    11. Funk E, Kottilil S, Gilliam B, Talwani R. Tickling the TLR7 to cure viral hepatitis. J Transl Med. 2014 May 14; 12:129. PMID: 24884741.
      Citations: 11     Fields:    Translation:Humans
    12. Osinusi A, Meissner EG, Lee YJ, Bon D, Heytens L, Nelson A, Sneller M, Kohli A, Barrett L, Proschan M, Herrmann E, Shivakumar B, Gu W, Kwan R, Teferi G, Talwani R, Silk R, Kotb C, Wroblewski S, Fishbein D, Dewar R, Highbarger H, Zhang X, Kleiner D, Wood BJ, Chavez J, Symonds WT, Subramanian M, McHutchison J, Polis MA, Fauci AS, Masur H, Kottilil S. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA. 2013 Aug 28; 310(8):804-11. PMID: 23982366.
      Citations: 120     Fields:    Translation:HumansCellsCTClinical Trials
    13. Sajadi MM, Redfield RR, Talwani R. Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection. AIDS. 2013 Jul 31; 27(12):1989-92. PMID: 23660578.
      Citations: 4     Fields:    Translation:HumansCells
    14. Sajadi MM, Pulijala R, Redfield RR, Talwani R. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors. AIDS. 2012 Sep 24; 26(15):1879-84. PMID: 22824629.
      Citations: 24     Fields:    Translation:HumansCells
    15. Talwani R, Yfantis HG, Flores Y, Knodell RG. Letter to the editor: "boutique" quality assurance. Am J Med Qual. 2012 Sep-Oct; 27(5):448. PMID: 22964656.
      Citations:    Fields:    Translation:Humans
    16. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Am Fam Physician. 2012 Jun 01; 85(11):1086-93. PMID: 22962880.
      Citations: 16     Fields:    Translation:HumansAnimals
    17. Gilliam BL, Patel D, Talwani R, Temesgen Z. HIV in Africa: Challenges and Directions for the Next Decade. Curr Infect Dis Rep. 2012 Feb; 14(1):91-101. PMID: 22143960.
      Citations: 3     
    18. Sajadi MM, Shakeri N, Talwani R, Howell CD, Pakyz R, Redfield RR, Parsa A. IL28B genotype does not correlate with HIV control in African Americans. Clin Transl Sci. 2011 Aug; 4(4):282-4. PMID: 21884517.
      Citations: 6     Fields:    Translation:Humans
    19. Nayak SU, Talwani R, Gilliam B, Taylor G, Ghosh M. Cryptococcal Meningitis in an HIV-Positive Pregnant Woman. J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr; 10(2):79-82. PMID: 21317164.
      Citations: 5     Fields:    Translation:Humans
    20. Talwani R, Gilliam BL, Howell C. Infectious diseases and the liver. Clin Liver Dis. 2011 Feb; 15(1):111-30. PMID: 21111996.
      Citations: 19     Fields:    Translation:Humans
    21. Sajadi MM, Shakeri N, Talwani R, Redfield RR. Hepatitis C infection in HIV-1 natural viral suppressors. AIDS. 2010 Jul 17; 24(11):1689-95. PMID: 20467290.
      Citations: 16     Fields:    Translation:HumansCells
    22. Forrest GN, Wagner LA, Talwani R, Gilliam BL. Lack of fluoroquinolone resistance in non-typhoidal salmonella bacteremia in HIV-infected patients in an urban US setting. J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec; 8(6):338-41. PMID: 19952286.
      Citations: 2     Fields:    Translation:HumansCells
    23. Amoroso A, Gilliam BL, Talwani R, Boyce C, Redfield RR, Davis CE. Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine. HIV Clin Trials. 2009 Sep-Oct; 10(5):320-3. PMID: 19906624.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    24. Ghosh M, Talwani R, Gilliam BL. Propionibacterium skull osteomyelitis treated with daptomycin. Clin Neurol Neurosurg. 2009 Sep; 111(7):610-2. PMID: 19450922.
      Citations: 6     Fields:    Translation:HumansCells
    25. Talwani R, Mackowiak PA, Blome SE. A 40-year old woman with headache. Am J Med Sci. 2008 Nov; 336(5):418-22. PMID: 19011399.
      Citations:    Fields:    Translation:Humans
    26. Riedel DJ, Talwani R, Gilliam BL. Double trouble. Am J Med. 2008 Feb; 121(2):110-2. PMID: 18261497.
      Citations:    Fields:    Translation:Humans
    27. Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug; 50(8):2751-5. PMID: 16870768.
      Citations: 52     Fields:    Translation:HumansCellsCTClinical Trials
    28. McCallum BJ, Amrol D, Horvath J, Inayat N, Talwani R. A case of allergic bronchopulmonary aspergillosis leading to pneumonia with unusual organisms. South Med J. 2005 Nov; 98(11):1135-8. PMID: 16351036.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    29. Starnes CT, Talwani R, Horvath JA, Duffus WA, Bryan CS. Brucellosis in two hunt club members in South Carolina. J S C Med Assoc. 2004 Apr; 100(4):113-5. PMID: 15162669.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    30. Postic B, Horvath JA, Talwani R. Antiviral treatment of human immunodeficiency virus infection: update for 2003. J S C Med Assoc. 2003 Jun; 99(6):148-53. PMID: 12886699.
      Citations:    Fields:    Translation:HumansCells
    31. Safdar A, Dommers MP, Talwani R, Thompson CR. Intracranial perineural extension of invasive mycosis: a novel mechanism of disease propagation by Aspergillus fumigatus. Clin Infect Dis. 2002 Sep 01; 35(5):e50-3. PMID: 12173149.
      Citations: 8     Fields:    Translation:HumansAnimals
    32. Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, Sha BE, Smith KY, Kessler HA. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):191-5. PMID: 12045682.
      Citations: 13     Translation:Humans